Canada eyes investment in test kit factory in Binh Dinh
VOV.VN - Gene Bio Medical Company (GBM), a leading biotechnology company in British Columbia, Canada, plans to build a test kit factory in the south-central province of Binh Dinh with a total investment of between US$10 - 20 million.

This information was released on February 25 at a meeting between the leaders of Binh Dinh Provincial People's Committee and a delegation of the Canadian Consulate General in Ho Chi Minh City, the British Columbia Office in Vietnam, and GBM.
Addressing the event, Jessica Hu, CEO and founder of GBM, introduced the firm’s profile, saying it develops advanced diagnostic tools to meet the needs of patients and healthcare providers worldwide.
In particular, GBM provided more than 48 million high-quality SARS-CoV-2 rapid test kits to the Canadian Government during the COVID-19 pandemic.
After conducting a survey in the Vietnamese market, GBM decided to invest between US$10 – 20 million in building a modern production facility in Binh Dinh to produce high-quality diagnostic test kits using Canadian technology.
For his part, Lam Hai Giang, vice chairman of Binh Dinh Provincial People's Committee, appreciated GBM’s investment plan and vowed to facilitate the implementation of the project.
Binh Dinh views investors' success as its own success and is committed to creating the most favorable conditions for investors, he told his guests, adding projects located in priority investment areas will receive Vietnam's highest government incentives, along with additional provincial incentives.
At the working session, GBM and Binh Dinh Pharmaceutical and Medical Equipment Joint Stock Company (Bidiphar) signed a Memorandum of Understanding (MoU) to build a state-of-the-art production facility in Binh Dinh.
The factory will manufacture high-quality diagnostic kits using Canadian technology, to serve Vietnam, Southeast Asia, the Middle East, and North America.
The joint venture will focus on pandemic preparedness and addressing emerging global health challenges. It also plans a five-year roadmap for listing on NASDAQ (USA) and the Vietnam Stock Exchange.